Literature DB >> 17889643

Non-oncogene addiction and the stress phenotype of cancer cells.

Nicole L Solimini1, Ji Luo, Stephen J Elledge.   

Abstract

Heat-shock factor 1 (HSF1) is a transcription factor that is activated upon proteotoxic stress and coordinates induction of the heat-shock response. In this issue, Dai et al. (2007) show that HSF1 is a potent modifier of tumorigenesis and is required for tumor initiation and maintenance in a variety of cancer models. These findings add HSF1 to a growing list of non-oncogenes that could be exploited as cancer drug targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889643     DOI: 10.1016/j.cell.2007.09.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  155 in total

1.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

Authors:  T L Ng; G Leprivier; M D Robertson; C Chow; M J Martin; K R Laderoute; E Davicioni; T J Triche; P H B Sorensen
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

3.  DNA methylation screening identifies driver epigenetic events of cancer cell survival.

Authors:  Daniel D De Carvalho; Shikhar Sharma; Jueng Soo You; Sheng-Fang Su; Phillippa C Taberlay; Theresa K Kelly; Xiaojing Yang; Gangning Liang; Peter A Jones
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

4.  KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.

Authors:  Young Ju Yoon; Joo Ae Kim; Ki Deok Shin; Dae-Seop Shin; Young Min Han; Yu Jin Lee; Jin Soo Lee; Byoung-Mog Kwon; Dong Cho Han
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

Review 5.  Signal transduction in cancer.

Authors:  Richard Sever; Joan S Brugge
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

6.  Double-stranded Let-7 mimics, potential candidates for cancer gene therapy.

Authors:  Qi-zhao Wang; Ying-hui Lv; Yu-hua Gong; Zhao-fa Li; William Xu; Yong Diao; Ruian Xu
Journal:  J Physiol Biochem       Date:  2011-11-09       Impact factor: 4.158

7.  IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model.

Authors:  H Kitamura; Y Onodera; S Murakami; T Suzuki; H Motohashi
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

8.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

Authors:  Yuliya Pylayeva; Kelly M Gillen; William Gerald; Hilary E Beggs; Louis F Reichardt; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

9.  IRF4 addiction in multiple myeloma.

Authors:  Arthur L Shaffer; N C Tolga Emre; Laurence Lamy; Vu N Ngo; George Wright; Wenming Xiao; John Powell; Sandeep Dave; Xin Yu; Hong Zhao; Yuxin Zeng; Bangzheng Chen; Joshua Epstein; Louis M Staudt
Journal:  Nature       Date:  2008-06-22       Impact factor: 49.962

10.  Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.

Authors:  Nickolay Neznanov; Anton V Gorbachev; Lubov Neznanova; Andrei P Komarov; Katerina V Gurova; Alexander V Gasparian; Amiya K Banerjee; Alexandru Almasan; Robert L Fairchild; Andrei V Gudkov
Journal:  Cell Cycle       Date:  2009-12-25       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.